logo
The world nearly beat polio, but missteps and fake records revived it

The world nearly beat polio, but missteps and fake records revived it

For the past decade, Sughra Ayaz has travelled door to door in southeastern Pakistan, pleading with parents to allow children to be vaccinated against polio to wipe out the paralytic disease.
She hears their demands and fears. Some are practical families need basics like food and water more than vaccines.
Amid rampant misinformation and immense pressure for the campaign to succeed, Ayaz said, some managers have instructed workers to falsely mark children as immunised. And the vaccines, which must be kept cold, aren't always stored correctly, she added.
The World Health Organisation and partners embarked on their polio campaign in 1988 with the bold goal of eradication a feat seen only once for human diseases, with smallpox in 1980. They came close several times, including in 2021, when just five cases of the natural virus were reported in Pakistan and Afghanistan. But since then, cases rebounded, hitting 99 last year, and officials missed at least six self-imposed eradication deadlines.
Afghanistan and Pakistan remain the only countries where transmission of polio occurs.
But in its quest to eliminate the disease, the Global Polio Eradication Initiative has been derailed by mismanagement and what insiders describe as blind allegiance to an outdated strategy, according to workers, polio experts and internal materials obtained by The Associated Press.
Officials have falsified vaccination records, selected unqualified people to dole out drops, failed to send out teams during mass campaigns, and dismissed concerns about the oral vaccinesparking outbreaks according to documents shared with AP by staffers from GPEI one of the largest public health campaigns, with over USD 20 billion spent and nearly every country in the world involved.
Officials tout the successes 3 billion children vaccinated, an estimated 20 million people who would have been paralysed spared while acknowledging challenges in Pakistan and Afghanistan. Remote villages are hard to reach, some cultural and religious authorities instruct against vaccination, and hundreds of polio workers and security staff have been killed because of their alignment with a Western-led initiative.
Dr. Jamal Ahmed, WHO's polio director, defended progress in those two countries, citing workers' tailored response in resistant pockets.
Ahmed said he believes authorities will end the spread of polio in the next 12 to 18 months. Its latest goal for eradication is 2029. The campaign says about 45 million children in Pakistan and 11 million in Afghanistan must be vaccinated this year. Children typically need four doses of two drops each to be considered fully immunised.
Dr. Zulfiqar Bhutta, who has served on advisory groups for WHO, the Gates Foundation and others, said campaign officials should listen to the criticism of its tactics.
Documents show years-long problems on polio vaccination teams.
The documents flagged multiple cases of falsified vaccination records, health workers being replaced by untrained relatives and workers improperly administering vaccines.
On numerous occasions, WHO officials noted, vaccinators did not know about vaccine management, citing failure to keep doses properly cold. They also found sloppy or falsified reporting, with workers noting more used vaccine vials than were actually supplied.
According to an August 2017 report from Kandahar, Afghanistan, local government authorities and others interfered in choosing vaccinators, resulting in the selection of underage and illiterate volunteers.
Vaccination teams worked in a hurried manner, reports said.
A team in Nawzad, Afghanistan, covered just half of the intended area in 2017, with 250 households missed entirely. Village elders said no one visited for at least two years.
Vaccine workers and health officials in Afghanistan and Pakistan confirmed the issues in the documents and told AP it's hard for campaign leadership to grasp the difficulties in the field. Door-to-door efforts are stymied by cultural barriers, unfounded stories about vaccines, and the region's poverty and transience.
In an email response to AP's questions about officials' knowledge of the issues, WHO polio director Ahmed noted operational challenges in Afghanistan and Pakistan and said the program has robust monitoring and evaluation processes.
Ayaz described fake finger marking placing the ink used to show a child is vaccinated on their pinky even when no vaccine has been given.
Critics point to the continued use of the oral polio vaccine.
Before the first polio vaccine was developed in 1955, the disease spread mostly from person to person, through contaminated water and via faecal particles was among the world's most feared, paralysing hundreds of thousands of children annually.
Polio is mainly spread when people are exposed to water infected with the virus. In countries with poor sanitation, children often become infected when they come into contact with contaminated waste.
WHO says that as long as a single child remains infected, kids everywhere are at risk.
Eradication demands near-perfection zero polio cases and immunising more than 95 per cent of children.
The oral vaccine proven to be safe and effective has been given to more than 3 billion children. But there are some extremely rare side effects: Scientists estimate that for every 2.7 million first doses given, one child will be paralysed by the live polio virus in the vaccine.
In even rarer instances, the live virus can mutate into a form capable of starting new outbreaks among unimmunized people where vaccination rates are low.
Worldwide, several hundred vaccine-derived cases have been reported annually since at least 2021, with at least 98 this year.
Most public health experts agree the oral vaccine should be pulled as soon as possible. But they acknowledge there simply isn't enough injectable vaccine which uses no live virus and doesn't come with the risks of the oral vaccine to wipe out polio alone. The injectable vaccine is also more expensive and requires more training to administer.
Dr. Tom Frieden, a former director of the US Centres for Disease Control and Prevention who sits on an independent board reviewing polio eradication, said it would be impossible to eliminate polio without the oral vaccine. But he's urged authorities to find ways to adapt, such as adopting new methods to identify polio cases more quickly. Since 2011, he and colleagues have issued regular reports about overall program failures.
Last year, former WHO scientist Dr. T. Jacob John twice emailed WHO Director-General Tedros Adhanom Ghebreyesus, calling for a course correction. John shared the emails with AP and said he's received no response.
In his response to AP, WHO polio director Ahmed said the oral vaccine is a core pillar of the eradication strategy and that almost every country that is polio-free today used (it) to achieve that milestone.
Ahmed also pointed to the success the WHO and partners had in eliminating polio from India, once considered a nearly impossible task. In the four years before polio was wiped out there, health workers delivered about 1 billion doses of the oral vaccine to more than 170 million children.
Today, nearly all of the world's polio cases -- mostly in Africa and the Middle East -- are mutated viruses from the oral vaccine, except for Afghanistan and Pakistan.
Scott Barrett, a Columbia University professor, called for an inquiry into how things went so wrong, particularly with a failed effort in 2016, when authorities removed a strain from the oral vaccine. They miscalculated, leading to outbreaks in more than 40 countries that paralysed more than 3,000 children, according to an expert report commissioned by WHO. Last year, a mutated virus traced to that effort paralysed a baby in Gaza.
Mistrust of the polio eradication effort persists.
With an annual budget of about USD 1 billion, the polio initiative is among the most expensive in all of public health. This year, the US withdrew from the WHO, and President Donald Trump has cut foreign aid. WHO officials have privately admitted that sustaining funding would be difficult without success.
Some say the money would be better spent on other health needs.
We have spent more than USD 1 billion in the last five years in Pakistan alone, and it didn't buy us any progress, said Roland Sutter, who formerly led polio research at WHO.
Villagers, too, have protested the cost, staging hundreds of boycotts of immunisation campaigns since 2023. Instead of polio vaccines, they ask for medicine, food and electricity.
In Karachi, locals told AP they didn't understand the government's fixation on polio and complained of other issues dirty water, heroin addiction. Workers are accompanied by armed guards; Pakistani authorities say more than 200 workers and police assigned to protect them have been killed since the 1990s, mostly by militants.
The campaign is also up against a wave of misinformation, including that the vaccine is made from pig urine or will make children reach puberty early. Some blame an anti-vaccine sentiment growing in the US and other countries that have largely funded eradication efforts and say it's reaching even remote areas of Afghanistan and Pakistan.
In suburban southwest Pakistan, Saleem Khan, 58, said two grandchildren under 5 were vaccinated over his family's objections.
It results in disability, said Khan, without citing evidence for his belief.
Svea Closser, professor of international health at Johns Hopkins University, said Pakistan and Afghanistan were less resistant to immunisation decades ago. Now, people are angry about the focus on polio and lack of help for diseases like measles or tuberculosis, she said, spurring conspiracy theories.
In a mountainous region of southeastern Afghanistan where most people survive by growing wheat and raising cows and chickens, a mother of five said she'd prefer that her children be vaccinated against polio, but her husband and other male relatives have instructed their families to reject it. They believe the false rumours that it will compromise their children's fertility.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealth Group (UNH) stock jumps 12% after Buffett's $1.6B stake — forecast predicts 24% upside, is UNH a must-buy?
UnitedHealth Group (UNH) stock jumps 12% after Buffett's $1.6B stake — forecast predicts 24% upside, is UNH a must-buy?

Time of India

time14 hours ago

  • Time of India

UnitedHealth Group (UNH) stock jumps 12% after Buffett's $1.6B stake — forecast predicts 24% upside, is UNH a must-buy?

UnitedHealth Group (UNH) shares soared 12% on August 15, 2025, after Warren Buffett's Berkshire Hathaway revealed a $1.6 billion stake of over 5 million shares. The surge marks the stock's biggest jump in five years, bringing it back above the key $300 level for the first time since mid-July. Analysts now see potential upside of more than 20%, making UNH a 'must-buy' for investors looking for stability in a turbulent healthcare market. UnitedHealth Group (UNH) stock jumped 12% on August 15, 2025, after Warren Buffett's Berkshire Hathaway revealed a $1.6 billion stake, snapping the insurer out of a recent slump. Shares climbed past the $300 mark, the first time since mid-July, and analysts are now forecasting a potential 24% upside. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Stock Price (Aug 15, 2025): $302.76 Intraday High/Low: $307.90 / $295 After-Hours Gain: 11% Shares Purchased by Berkshire Hathaway: 5 million+ Berkshire Cash Reserve: $344 billion Buffett's Strategic Bet: A Signal of Long-Term Confidence Buffett's broader portfolio strategy Berkshire trimmed Apple (AAPL) and Bank of America (BAC) positions Initiated new stakes in homebuilders like D.R. Horton (DHI) and Lennar Corp Added shares in industrial steelmaker Nucor (NUE) Market Reaction: Berkshire Hathaway's Portfolio Moves Current Price: $302.65 USD $302.65 USD Price Change: +$31.16 (+11.48%) from previous close of $271.49 +$31.16 (+11.48%) from previous close of $271.49 Opening Price: $301.00 USD $301.00 USD Intraday High: $307.90 USD $307.90 USD Intraday Low: $295.00 USD $295.00 USD After-Hours Movement: Shares surged following Buffett's investment announcement Shares surged following Buffett's investment announcement Trading Volume: 30,116,349 shares 30,116,349 shares Key Trigger: Berkshire Hathaway bought over 5 million UnitedHealth shares, valued at ~$1.6 billion Berkshire Hathaway bought over 5 million UnitedHealth shares, valued at ~$1.6 billion Market Sentiment: Strong investor confidence despite regulatory scrutiny over Medicare Advantage billing practices Strong investor confidence despite regulatory scrutiny over Medicare Advantage billing practices Implication: Seen as a vote of confidence in UnitedHealth's long-term growth and stability What this means for UnitedHealth and investors Tired of too many ads? Remove Ads Confidence boost amid regulatory scrutiny: Investors may view Buffett's vote as a backstop to share price volatility. Potential support for growth initiatives: Medicare Advantage expansion and other healthcare services could receive renewed focus. Short-term price resilience: The $300 psychological level may act as a recovered support level, with resistance near $342 and potential upside toward $376.84. Stock forecast and outlook Near-term resistance: $342 $342 Mid-term gap fill: $376.84 $376.84 Long-term former support: $438.50 Expert Takeaway: FAQs: UnitedHealth Group (UNH) stock soared on August 15, 2025, hitting its best day in five years after Warren Buffett's Berkshire Hathaway disclosed a $1.6 billion purchase of over 5 million shares. The move sent the healthcare giant's stock up 12% in after-hours trading, signaling strong investor confidence despite recent regulatory and financial say Buffett's entry comes at a critical time, as UnitedHealth navigates regulatory scrutiny over Medicare Advantage billing practices and has faced a roughly 15% decline in stock value over the past Analysts now see potential upside of more thanfor investors looking for stability in a turbulent healthcare see this as a major endorsement from one of the world's most respected investors, suggesting that UnitedHealth's long-term growth prospects remain robust, particularly in its diversified healthcare services and expanding Medicare Advantage surge also reflects broader market optimism, as institutional and retail investors often follow Buffett's high-profile moves, betting on stability and resilience in a volatile healthcare investment comes as UnitedHealth navigates a challenging landscape. The company has faced federal scrutiny over its Medicare Advantage billing practices and a notable drop in stock value over the past year. Yet, Berkshire Hathaway's purchase is being interpreted by analysts as a robust vote of confidence."Buffett rarely invests on a whim," says financial analyst Linda Chen of Apex Capital. "This signals that UnitedHealth's fundamentals, especially its diversified healthcare services and strong market position, remain highly attractive for long-term investors."This acquisition is part of a strategic reshuffle at Berkshire Hathaway. In Q2 2025:The firm retains a cash reserve of $344 billion, giving Buffett ample room for strategic bets in undervalued or high-potential stock closed at, climbingin after-hours trading on August 15. Intraday, the stock hit a high ofand a low of, with a trading volume exceeding. The sharp uptick reflects investor optimism that Buffett's involvement could stabilize sentiment and boost confidence in UnitedHealth's growth acquisition is part of broader strategic changes in Berkshire Hathaway's portfolio. According to the latest 13F filing, Buffett's firm reduced its stake in Apple by 7%, while initiating new positions in homebuilders likeand, and industrial steel producer. The moves suggest a diversification strategy into sectors with potential long-term gains, even as Berkshire holds a substantial cash reserve ofBuffett's entry could stabilize market sentiment and attract additional institutional interest. For UnitedHealth, the implications include:However, regulatory risks remain. Investigations into Medicare Advantage billing practices could still impact earnings and valuation in the near analysts see UNH trading above its 50-day Simple Moving Average (SMA) for the first time since April, signaling a possible bullish trend. Key targets include:While short-term traders may celebrate the 11% surge, seasoned investors recognize Buffett's hallmark: patient, long-term investing. His move is less about immediate gains and more about UNH's enduring market position and operational short-term traders may celebrate the after-hours surge, seasoned investors recognize Buffett's hallmark: patient, long-term investing. This move underscores his confidence not in immediate gains but in UnitedHealth's enduring market position, operational efficiency, and healthcare sector growth did Warren Buffett invest in UnitedHealth stock today?Buffett bought over $1.6B in UnitedHealth shares, showing confidence in the company's growth and long-term did UnitedHealth shares react after Buffett's purchase?UnitedHealth stock soared 11% after-hours, reaching $302.76, reflecting strong investor optimism.

Women Are At A Higher Risk Of Dementia: Here's Why
Women Are At A Higher Risk Of Dementia: Here's Why

NDTV

time16 hours ago

  • NDTV

Women Are At A Higher Risk Of Dementia: Here's Why

Dementia is a term used to describe several diseases that affect memory, thinking and social abilities. It is characterised by a decline in cognitive function which interferes with a person's daily life. Memory loss is the earliest symptom of dementia. Alzheimer's disease is the most common type, but there are other causes. Dementia risk in women Dementia can affect people differently. Research consistently shows that women are at a higher risk of developing dementia, particularly Alzheimer's disease. According to the Alzheimer's Association, nearly two-thirds of Americans living with Alzheimer's are women. Here are some reasons why: Longevity: Women generally live longer than men, and age is the biggest risk factor for dementia. Biological differences: Hormonal changes, especially the drop in estrogen after menopause, may increase vulnerability. Genetic factors: Certain genes, such as APOE-e4, may affect women more than men in terms of dementia risk. The World Health Organisation has reported that women are disproportionately affected globally, comprising 65% of Alzheimer's cases. What are the other risk factors for dementia? Age: Risk increases significantly after age 65. Genetics: Family history and gene variants, such as APOE-e4. Cardiovascular issues: Hypertension, diabetes, high cholesterol, and obesity may increase the risk. Poor lifestyle: Smoking, excessive alcohol use, poor diet, and lack of exercise. Mental health: Depression and chronic stress are also common risk factors for dementia. Brain injuries: Traumatic brain injuries or repeated head trauma. Hearing loss: Having hearing loss is associated with a higher risk of dementia. Sleep disorders: Poor sleep quality or sleep apnea is also a risk factor for dementia. How to lower dementia risk Studies indicate that exercising regularly, eating right, quitting smoking and ensuring quality sleep help reduce the risk of dementia. Additionally, staying mentally fit and preventing head injuries also helps lower the risk. While women are at a higher risk of dementia, many risk factors can be managed through lifestyle and health interventions. Early action through exercise, diet, mental stimulation, and managing chronic conditions can help lower the risk and support brain health throughout life. Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.

Kerala's 'Cancer free Kannapuram' programme gets recognised by WHO
Kerala's 'Cancer free Kannapuram' programme gets recognised by WHO

Business Standard

time18 hours ago

  • Business Standard

Kerala's 'Cancer free Kannapuram' programme gets recognised by WHO

The Cancer-Free Kannapuram initiative, launched in 2016 in Kerala's Kannapuram gram panchayat, has been officially recognised by the World Health Organization (WHO) for its remarkable impact on early detection and control of cancer. This model, rooted in community participation and effective local leadership, has emerged as a replicable template for similar efforts worldwide. What is the Kannapuram model? The model integrates over a decade of community engagement, mobilising local stakeholders under the Gram Panchayat's leadership alongside technical support from a Comprehensive Cancer Care Centre (CCCC). Phase 1: Sensitisation workshops were held, uniting local self-government representatives, primary health staff, and self-help groups with doctors, to raise awareness and form grassroots committees. A comprehensive door-to-door survey followed, identifying high-risk individuals while also exposing deep-rooted fear and misinformation about cancer. Phase 2: This phase included distributing information, education, and communication (IEC) materials, hosting health exhibitions at community events, organising 'winners meets' where survivors shared experiences to reduce fear. It also featured literary competitions, panel discussions on diet and cancer prevention, kitchen garden promotion, and school campaigns on cancer and tobacco with Parent-Teacher Association support. Phase 3: The gram panchayat launched a breast cancer screening project, starting with a single-day registration drive covering 3,800 homes. A 10-day mega camp followed, screening healthy women over 30 with no breast cancer history. Trained female technicians examined 200–500 women daily. Participants received pamphlets and training on self-examination. Women with positive results were counselled and referred to the CCCC for further tests, supported by a dedicated team that coordinated appointments, travel, and follow-ups, ensuring smooth access to care. Impressive outcomes A staggering 96 per cent of eligible women participated in the screening camp, and the detection rate was 0.96 per 1,000. More tests were required for 6.2 per cent of women, according to the positivity in the screening test and findings of the CBE. The majority of them, making up 84 per cent, had no symptoms. Further assessment participation rate either at the CCCC or elsewhere was 66.5 per cent due to continuous intervention and motivation by the volunteers despite having no symptoms. Why the model succeeded Continuous awareness drives, women-led leadership, and community trust were key to the programme's success. As noted in the WHO South-East Asia Journal of Public Health paper on the initiative, 'In our study, the continuous awareness campaigns led by female members, acceptable and cost-free screening methods, well-organised screening camps with female providers, and the geographically accessible campsite led to increased screening participation. The involvement of the community helped to overcome most of the barriers at large, address the possible mistrust between the health system and the public, and sustain the interventions to achieve the goal.' Kannapuram gram panchayat president Rethi K told Deccan Herald that the initiative's success lay in removing the stigma around cancer and ensuring regular screening camps. "We initiated the programme after it came to our notice that many people in the panchayat were suffering from cancer, especially women, and many were reluctant to rule out suspicions owing to fear and stigma. The awareness camps really helped in addressing these issues. As a result, 96 percent of women above the age of 30 could be screened," she said. The Kannapuram model exemplifies how community-driven health initiatives can transform cancer screening and outcomes. It aligns with the WHO's Global Breast Cancer Initiative, which identifies three key pillars for reducing breast cancer mortality: health promotion and early detection, timely diagnosis, and comprehensive cancer management.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store